KOBOCommodity Chemicals
Kobo Biotech Ltd — Profit & Loss Statement
₹2.23
+1.30%
Kobo Biotech Ltd Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized EBITDA | -0.86 Cr | -1.48 Cr | 112.13 Cr | -2.79 Cr |
| Total Unusual Items | 0.00 | 0.00 | -122.62 Cr | 0.00 |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -122.62 Cr | 0.00 |
| Net Income From Continuing Operation Net Minority Interest | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Reconciled Depreciation | 4.07 Cr | 4.07 Cr | 4.61 Cr | 5.64 Cr |
| Reconciled Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -0.86 Cr | -1.48 Cr | -10.49 Cr | -2.79 Cr |
| EBIT | -4.93 Cr | -5.55 Cr | -15.09 Cr | -8.43 Cr |
| Net Interest Income | -1000.00 | -2000.00 | -0.12 Cr | -10.80 Cr |
| Interest Expense | 1000.00 | 2000.00 | 0.13 Cr | 10.80 Cr |
| Normalized Income | -4.93 Cr | -5.55 Cr | 107.39 Cr | -19.23 Cr |
| Net Income From Continuing And Discontinued Operation | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Total Expenses | 4.94 Cr | 5.57 Cr | -116.47 Cr | 7.84 Cr |
| Diluted Average Shares | 2.38 Cr | 2.38 Cr | 2.38 Cr | 2.38 Cr |
| Basic Average Shares | 2.38 Cr | 2.38 Cr | 2.38 Cr | 2.38 Cr |
| Diluted EPS | -2.07 | -2.33 | -6.39 | -8.07 |
| Basic EPS | -2.07 | -2.33 | -6.39 | -8.07 |
| Diluted NI Availto Com Stockholders | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Net Income Common Stockholders | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Net Income Including Noncontrolling Interests | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Net Income Continuous Operations | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Pretax Income | -4.93 Cr | -5.55 Cr | -15.23 Cr | -19.23 Cr |
| Other Non Operating Income Expenses | 0.02 Cr | 0.02 Cr | 0.02 Cr | 0.04 Cr |
| Special Income Charges | 0.00 | 0.00 | -122.62 Cr | 0.00 |
| Net Non Operating Interest Income Expense | -1000.00 | -2000.00 | -0.12 Cr | -10.80 Cr |
| Interest Expense Non Operating | 1000.00 | 2000.00 | 0.13 Cr | 10.80 Cr |
| Operating Income | -4.94 Cr | -5.57 Cr | 116.47 Cr | -7.84 Cr |
| Operating Expense | 4.94 Cr | 5.57 Cr | -116.47 Cr | 7.84 Cr |
| Other Operating Expenses | 0.62 Cr | 1.27 Cr | 0.61 Cr | 0.72 Cr |
| Depreciation And Amortization In Income Statement | 4.07 Cr | 4.07 Cr | 4.61 Cr | 5.64 Cr |
| Depreciation Income Statement | 4.07 Cr | 4.07 Cr | 4.61 Cr | 5.64 Cr |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Income | — | 0.02 Cr | 0.02 Cr | 0.04 Cr |
| Rent Expense Supplemental | — | 0.01 Cr | 0.02 Cr | 26000.00 |
| Average Dilution Earnings | — | 0.00 | 0.00 | — |
| Preferred Stock Dividends | — | 0.00 | 0.00 | — |
| Net Income Discontinuous Operations | — | 0.00 | 0.00 | — |
| Write Off | — | 0.00 | 111.98 Cr | 0.00 |
| Impairment Of Capital Assets | — | 0.00 | 10.64 Cr | 0.00 |
| Total Other Finance Cost | — | 2000.00 | 5000.00 | 0.04 Cr |
| Interest Income Non Operating | — | 0.02 Cr | 0.02 Cr | 0.04 Cr |
| Selling General And Administration | — | 0.11 Cr | 0.08 Cr | 0.09 Cr |
| General And Administrative Expense | — | 0.11 Cr | 0.08 Cr | 0.09 Cr |
| Rent And Landing Fees | — | 0.01 Cr | 0.02 Cr | 26000.00 |
| Other Special Charges | — | — | -122.07 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kobo Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.